Zoetis | ZTS - Betriebsergebnis





Betriebsergebnis Veränderung Datum
AbbVie USD 4.73B 1.08B 2026-03
Align Technology USD 178.05M 46.66M 2026-03
Bayer EUR 3.53B 2.42B 2026-03
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Charles River Laboratories USD 119.9M 44.08M 2026-03
Coherus Biosciences USD -39.08M 3.65M 2025-12
Dentsply International USD 32M 506M 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Henry Schein USD 182M 4M 2026-03
Idexx Laboratories USD 362.59M 46.98M 2026-03
Illumina USD 239M 17M 2026-03
IQVIA Holdings USD 565M 2.11B 2026-03
J&J USD 6.62B 1.03B 2026-03
Laboratory Of America USD 410.1M 28.1M 2026-03
Merck USD -1.88B 8.12B 2026-03
Neogen USD -3.3M 2.08M 2025-12
Pacira USD 4.62M 1.43M 2026-03
Perrigo USD 33.6M 50.8M 2026-03
Pfizer USD 4.99B 340M 2026-03
Phibro Animal Health USD 54.99M 2.36M 2025-12
Quest Diagnostics USD 399M 13M 2026-03
Sanofi EUR 1.94B 239M 2026-03
Sanofi EUR 1.5B 2.29B 2025-12
Zoetis USD 865M 30M 2026-03